Hirschsprung's Disease (Congenital Aganglionic Megacolon)

  1. Overview and Epidemiology
  2. Genetics and Molecular Pathogenesis
  3. Anatomy of Aganglionosis
  4. Pathophysiology and Clinical Presentation
  5. Diagnosis
  6. Surgical Treatment
  7. Postoperative Outcomes and Complications
  8. HAEC Recognition and Management
  9. Key Research Papers
  10. Connections
  11. Featured Videos

Overview and Epidemiology

Hirschsprung's disease (HD), also called congenital aganglionic megacolon, is a congenital defect characterized by the complete absence of ganglion cells (aganglionosis) in the distal bowel. It results from failure of neural crest cells to migrate fully into the hindgut during embryonic development — a process that normally completes between weeks 5 and 12 of gestation. Without ganglion cells, the affected segment of bowel cannot relax or coordinate peristalsis, creating a functional obstruction that causes the normally-innervated proximal bowel to balloon outward: the megacolon.

HD occurs in approximately 1 in 5,000 live births worldwide and is one of the most common causes of neonatal intestinal obstruction. The condition affects males far more often than females in its most common (short-segment) form, with a male-to-female ratio of approximately 4:1. This ratio narrows toward 1:1 in long-segment disease, which is more uniformly distributed across sexes and carries a higher genetic burden.

Most cases are sporadic, but familial clustering is well recognized. Important disease associations include:

Back to Table of Contents

Genetics and Molecular Pathogenesis

HD is a complex genetic disorder in which multiple genes, each with incomplete penetrance, contribute to disease risk. Understanding the genetics is increasingly important as genetic counseling, cancer surveillance, and family planning decisions depend on identifying the causative variant.

RET proto-oncogene (chromosome 10q11.21) is the major susceptibility gene. RET encodes a receptor tyrosine kinase expressed on enteric neural crest cells (NCC). Its signaling is driven by the GDNF (glial cell line-derived neurotrophic factor) / GFRα1 ligand complex. RET activation promotes NCC survival, proliferation, and caudal migration through the developing gut. Loss-of-function mutations in RET — numbering in the hundreds — impair this process and are found in:

The penetrance of RET mutations is incomplete and sex-influenced — males with a pathogenic RET variant have a much higher lifetime risk of HD than females, explaining the strong male predominance in short-segment disease.

Other HD-associated genes and their pathways:

Inheritance patterns vary by segment length and gene involved. Short-segment HD behaves as a low-penetrance dominant trait with strong sex bias; long-segment HD often has higher heritability and may follow more Mendelian patterns when a single high-penetrance gene is involved. Genetic testing panels for HD should include at minimum RET, EDNRB, EDN3, and SOX10 in familial cases or cases with associated anomalies.

Back to Table of Contents

Anatomy of Aganglionosis

Understanding where the aganglionic segment begins and how far it extends is fundamental to both diagnosis and surgical planning. There is one anatomical invariant: the aganglionic segment always begins at the internal anal sphincter (IAS) and extends proximally to a variable length. There is no form of HD in which the distal rectum is spared. This is why a normal rectal biopsy at the appropriate level essentially excludes HD.

The normally-innervated bowel contains two ganglionated plexuses:

In HD, both plexuses are absent from the aganglionic segment. This total absence of inhibitory neuronal input means the IAS and the aganglionic bowel remain in a state of tonic contraction, incapable of the coordinated relaxation that normally allows stool to pass.

The transition zone (TZ) — the region between the aganglionic distal bowel and the normally-ganglionated proximal bowel — shows irregular and hypoganglionic (sparse, immature) ganglion cells. Pathologically, the TZ is characterized by hypertrophied, acetylcholinesterase-positive nerve trunks in the submucosa. The TZ is diagnostically important and surgically critical: pull-through procedures must place the anastomosis well above the TZ in fully-ganglionated bowel.

Classification by segment length:

Back to Table of Contents

Pathophysiology and Clinical Presentation

The core pathophysiological defect is straightforward: without ganglion cells, the distal bowel cannot relax on command. Stool that reaches the aganglionic segment encounters a tonically contracted segment that acts as a mechanical valve. Proximal bowel distends as stool accumulates above the obstruction — hence megacolon. The rectoanal inhibitory reflex (RAIR) — the normal reflex relaxation of the IAS when the rectum is distended — is absent in HD. This is the physiological basis for anorectal manometry as a diagnostic test.

Neonatal presentation (the majority of HD is diagnosed in the newborn period):

Presentation in older children (milder cases missed in the neonatal period, or ultrashort-segment HD):

Hirschsprung-Associated Enterocolitis (HAEC) is the most feared acute complication of HD, responsible for the majority of HD-related deaths. HAEC occurs in 15–50% of patients with HD, most commonly in the first months of life before diagnosis (pre-operative HAEC) but also after a technically successful pull-through procedure (post-operative HAEC). Pathogenesis involves bacterial overgrowth in the massively distended proximal bowel, disruption of the mucus barrier, bacterial translocation, and an overwhelming inflammatory cascade. Clinical presentation: fever + explosive foul-smelling diarrhea + severe abdominal distension. The "squirt sign" on rectal exam — explosive discharge when a rectal tube is inserted — is pathognomonic. Without prompt treatment, HAEC progresses to septic shock and colonic perforation. HAEC is a surgical emergency requiring immediate hospitalization, IV antibiotics, and rectal irrigations.

Back to Table of Contents

Diagnosis

The diagnosis of HD rests on three complementary modalities. No single test is 100% sensitive and specific; the clinical picture must integrate all available data. In a newborn with failure to pass meconium and abdominal distension, diagnostic workup should proceed urgently.

Rectal suction biopsy — the gold standard: A suction biopsy device is used to take 3 small mucosal and submucosal specimens at 2, 3, and 4 cm above the dentate line (sampling below 2 cm is unreliable because there is a normal physiologic hypoganglionic zone immediately above the dentate line in all infants). The pathologist evaluates:

Rectal suction biopsy can be performed at the bedside without general anesthesia in neonates and young infants. A full-thickness biopsy under general anesthesia is reserved for cases where suction biopsy is technically inadequate or histologically inconclusive. Calretinin immunostaining is increasingly used as an adjunct — calretinin-positive ganglion cells and nerve fibers are present in normal bowel but absent in aganglionic bowel.

Contrast enema: A water-soluble contrast enema (barium avoided in acutely ill neonates due to perforation risk) is performed without prior rectal preparation (which would wash out the transition zone). The lateral view is the most informative. Classic findings:

Anorectal manometry: Measures the RAIR by inflating a small rectal balloon and recording internal anal sphincter pressure. In normal individuals (even preterm infants beyond ~26 weeks), rectal distension causes reflex relaxation of the IAS. In HD, the RAIR is absent — the IAS fails to relax, or may paradoxically contract. Anorectal manometry has sensitivity and specificity exceeding 90% for HD in experienced hands and is particularly useful for evaluating older children with constipation and for post-operative surveillance. It requires technical expertise and is less reliable in very young neonates.

Key clinical rule: Any child with constipation that began at or near birth — without an identifiable trigger and without a period of normal stooling — should be evaluated for HD until proven otherwise. Functional constipation in a true newborn (the first month of life) is a diagnosis of exclusion.

Back to Table of Contents

Surgical Treatment

The definitive treatment of HD is surgical removal of the aganglionic segment with a pull-through procedure — mobilizing normally-ganglionated proximal bowel and bringing it down to the anal verge to create a new, functional anastomosis. The goal is to restore propulsive peristalsis to the rectal outlet while preserving the voluntary external anal sphincter mechanism responsible for continence.

Historical procedures — understanding these helps explain why multiple modern approaches exist and what each prioritizes:

Modern laparoscopic and transanal approaches:

Timing and staging:

Pre-operative rectal irrigations: For infants awaiting pull-through, saline irrigations via a rectal catheter are performed twice daily to decompress the obstructed bowel and reduce the risk of HAEC. Parents are taught the technique for home use; this intervention significantly reduces pre-operative morbidity.

Back to Table of Contents

Postoperative Outcomes and Complications

The long-term prognosis for HD treated at experienced pediatric surgical centers is generally excellent. The majority of children with short-segment HD achieve socially acceptable fecal continence and lead normal lives. However, a meaningful minority experience ongoing bowel dysfunction that requires continued management, and families should be counseled realistically about the trajectory of improvement — which often extends well into adolescence.

Functional outcomes:

Common postoperative complications:

Quality of life: Long-term studies consistently show that the majority of HD patients report good quality of life (QoL). QoL scores continue to improve through adolescence. Psychosocial support — addressing body image, school performance, and peer relationships in children with soiling — is an integral part of long-term HD management. Adolescents who had HD as infants benefit from transition programs that prepare them to manage their own bowel health as adults.

Back to Table of Contents

HAEC Recognition and Management

Hirschsprung-Associated Enterocolitis (HAEC) is the most dangerous complication of HD and the leading cause of HD-related death. Every parent of a child with HD — diagnosed or suspected — must know how to recognize it and when to seek emergency care. Every clinician caring for a neonate with abdominal distension and fever must consider HAEC before assuming infectious gastroenteritis.

Pathogenesis: The obstructed, distended proximal bowel provides a reservoir for bacterial overgrowth. The mucus barrier — which normally prevents bacterial attachment to the colonic epithelium — is disrupted in HD patients due to altered mucin composition and goblet cell function. Bacterial translocation triggers a cascade of epithelial injury, cytokine release, and systemic inflammation. The organisms most commonly implicated include Clostridium difficile, Cryptosporidium, and aerobic gram-negative bacteria, though HAEC is often polymicrobial. The exact initiating event varies; HAEC can recur even after resolution of the primary obstruction via pull-through.

Clinical recognition — the HAEC triad:

Additional features: lethargy, poor feeding, vomiting, signs of dehydration, and in severe cases, peritoneal signs suggesting impending perforation. HAEC can progress to septic shock within hours.

Grading: The Pastor HAEC score (based on history, examination, and radiographic findings) stratifies severity and guides urgency of intervention. Radiographs of the abdomen may show dilated loops of bowel, air-fluid levels, pneumatosis intestinalis (gas within the bowel wall — a sign of mucosal ischemia and impending perforation), or free air indicating perforation.

Acute management:

Prevention and long-term management of recurrent HAEC: Families of all HD patients — both pre-operative and post-operative — should be taught rectal irrigation technique for home use when HAEC risk is elevated. Post-operative patients at high risk for recurrent HAEC (those with prior episodes, total colonic HD, or Down syndrome) benefit from regular prophylactic irrigations and/or oral probiotics (early data suggest Lactobacillus-based preparations may reduce HAEC frequency). Close surveillance and a low threshold for IV antibiotics at the first sign of recurrence are essential.

Back to Table of Contents

Key Research Papers

  1. Amiel J et al. — Hirschsprung disease, associated syndromes and genetics: a review — Journal of Medical Genetics — PMID: 18806761 — Comprehensive review of the molecular genetics of HD covering RET, EDNRB, EDN3, SOX10, and other loci; discusses penetrance, phenotype-genotype correlations, and genetic counseling implications.
  2. Langer JC — Hirschsprung disease — Current Problems in Surgery — PMID: 16631285 — Detailed surgical review covering the historical evolution of pull-through procedures (Swenson, Duhamel, Soave) through to modern laparoscopic and transanal approaches, with outcome data for each technique.
  3. De la Torre-Mondragón L, Ortega-Salgado JA — Transanal endorectal pull-through for Hirschsprung's disease — Journal of Pediatric Surgery — PMID: 10524633 — Seminal description of the modern single-stage transanal endorectal pull-through technique that has become standard of care for short-segment HD.
  4. De Lorijn F et al. — Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests — Journal of Pediatrics — PMID: 17499584 — Prospective head-to-head comparison of rectal biopsy, anorectal manometry, and contrast enema for HD diagnosis; established the superior sensitivity and specificity of rectal biopsy as the gold standard.
  5. Gosain A — Established and emerging concepts in Hirschsprung's-associated enterocolitis — Pediatric Surgery International — PMID: 22341570 — Reviews the pathogenesis of HAEC including disrupted mucosal barrier function, altered microbiome, and inflammatory mediators; discusses risk factors and preventive strategies.
  6. Swenson O — My early experience with Hirschsprung's disease — Journal of Pediatric Surgery — PMID: 11479837 — Orvar Swenson's personal account of developing the first curative pull-through procedure in 1948 and the clinical observations that led to understanding HD as a ganglionic disorder.
  7. Ieiri S et al. — Long-term outcomes and the quality of life of Hirschsprung disease in adolescents who have reached 18 years of age or older — Journal of Pediatric Surgery — PMID: 24657119 — Long-term follow-up study of HD patients into adulthood; documents fecal continence rates, QoL scores, and social outcomes; shows ongoing improvement through adolescence.
  8. Frykman PK, Short SS — Hirschsprung-associated enterocolitis: prevention and therapy — Seminars in Pediatric Surgery — PMID: 26947580 — Practical clinical review of HAEC prevention, recognition, grading, and management including the role of rectal irrigations, antibiotics, and surgical intervention thresholds.
  9. Engum SA, Grosfeld JL — Long-term results of treatment of Hirschsprung's disease — Seminars in Pediatric Surgery — PMID: 20951591 — Large institutional series reporting long-term functional outcomes across multiple pull-through techniques; documents rates of constipation, soiling, HAEC recurrence, and need for redo procedures.
  10. Rescorla FJ et al. — Hirschsprung's disease: evaluation of mortality and long-term function in 260 cases — Archives of Surgery — PMID: 7688108 — Classic long-term outcome series from Indiana University covering 260 patients; established benchmark mortality and functional outcome data that guided surgical decision-making for decades.
  11. PubMed: Hirschsprung disease RET mutation genetics — Search for current literature on RET proto-oncogene mutations and their role in HD pathogenesis, penetrance, and genetic counseling.
  12. PubMed: Hirschsprung disease Down syndrome epidemiology — Search for studies on the co-occurrence of HD and trisomy 21, including incidence data and management considerations in this high-risk population.

Back to Table of Contents

Connections

Back to Table of Contents